Tuesday, 02 January 2024 12:17 GMT

Allergy Treatment Global Forecast Report 2025: Market To Grow By Over $20 Billion By 2033, Driven By By Accelerated Illness Prevalence, Climate-Driven Allergy Amplification, And Innovative Biologics


(MENAFN- GlobeNewsWire - Nasdaq) The Allergy Treatment Market is projected to grow from USD 21.08 billion in 2024 to USD 41.93 billion by 2033, with a CAGR of 7.94% from 2025 to 2033. This growth is propelled by rising allergy prevalence, climate changes, and innovative biologics. Digital health models are enhancing access and adherence. Key drivers include increased allergic conditions, advances in biologics and immunotherapy, and heightened awareness and diagnosis. The market faces challenges like costly advanced treatments and patient adherence issues. North America and Europe lead in innovation, while Asia-Pacific shows rapid growth due to increased healthcare access and awareness.

Dublin, Sept. 29, 2025 (GLOBE NEWSWIRE) -- The "Allergy Treatment Global Market Report by Type, Treatment, Dosage Form, Distribution Channel, Countries and Company Analysis, 2025-2033" report has been added to ResearchAndMarkets's offering.
Allergy Treatment Market is expected to reach US$ 41.93 billion by 2033 from US$ 21.08 billion in 2024, with a CAGR of 7.94% from 2025 to 2033. Demand is being lifted by accelerated illness prevalence, climate-driven allergy amplification, and innovative biologics, while access and adherence are being expanded by new digital health models.

While Asia-Pacific is developing quickly as a result of rising prevalence, expanded healthcare access, and growing awareness among urban and semi-urban populations, North America and Europe continue to lead in the development and adoption of allergy treatments.


As allergic diseases such dermatitis, rhinitis, asthma, and food allergies become more prevalent globally, the market for allergy treatments is expanding significantly. This trend is being influenced by a number of factors, including shifting lifestyles, urban pollution, and increased exposure to allergens. Early diagnosis, cutting-edge treatment options, and long-term management of allergies employing immunotherapy, antihistamines, corticosteroids, and biologic medications are the main priorities of healthcare practitioners and pharmaceutical businesses. The effectiveness of treatment and patient outcomes are being improved by advancements in medication delivery systems and allergy testing techniques. Increased consumer knowledge and proactive healthcare-seeking behavior are also helping the sector.

Digital health platforms and public health campaigns are essential for informing patients about allergy symptoms, prevention, and available treatments. A move toward individualized medicine in allergy treatment is also made possible by research into genetic and environmental variables, which is producing more focused treatments. Access to specialists has become even easier with the growth of telemedicine and digital consultations, particularly in industrialized and urban areas.
But issues including underdiagnosis in low-income areas, the cost of treatment, and the requirement for long-term therapy still exist. Market dynamics are also influenced by patient adherence, regulatory approvals, and the safety profile of specific medications. Notwithstanding these challenges, the market is anticipated to rise as a result of ongoing R&D spending and growing healthcare infrastructure. The market for allergy treatments is expected to increase steadily across a range of age groups and geographical areas due to the rising prevalence of allergic illnesses worldwide.
Key Factors Driving the Allergy Treatment Market Growth

Growing Allergic Condition Prevalence:
One of the main factors propelling the worldwide market for allergy treatments is the rising number of people who suffer from allergies. Food, skin, and respiratory allergies are on the rise as a result of increased exposure to allergens brought on by urbanization, industrialization, and environmental pollution.

All age groups are impacted by this trend, but children and the elderly are most affected, which increases the need for affordable and efficient therapies. Healthcare systems and pharmaceutical corporations are now concentrating on early diagnosis, preventive care, and tailored medicines as a result of the rising occurrence. In both developed and developing countries, the market for therapies is growing as allergies become more common and persistent.
Developments in Biologics and Immunotherapy:
The treatment of severe and persistent allergies is being revolutionized by immunotherapy and biologic therapies. By desensitizing patients to certain allergens, subcutaneous and sublingual immunotherapies provide long-term comfort and lessen reliance on symptomatic medications. For complex allergic disorders including severe asthma and persistent urticaria, biologics like monoclonal antibodies offer focused therapy.

Better patient outcomes, reduced side effects, and increased efficacy are all provided by these medicines. Patients and medical professionals are drawn to the expanding array of customized immunotherapy alternatives. The development and uptake of advanced medicines are being accelerated by ongoing research and advantageous regulatory processes, making them a major growth driver in the field of allergy treatment.
Growing Rates of Awareness and Diagnosis:
Diagnoses and treatment rates are rising as a result of growing public knowledge of allergies and their effects on health. Patients are now more equipped to identify symptoms and seek medical attention sooner because to educational initiatives, wearable technologies, and digital health tools.

More precise detection of allergen sensitivities is made possible by advancements in diagnostic technology, such as component-resolved diagnostics and quick testing kits. Additionally, this increased awareness is pushing medical professionals to give allergy testing top priority, particularly for high-risk groups. The need for over-the-counter and prescription allergy medications is growing as knowledge and access to diagnostics increase worldwide, especially in emerging nations.
Challenges in the Allergy Treatment Market

Expensive and Hard to Get Advanced Treatments:
Many patients may find advanced allergy treatments, such as biologics and tailored immunotherapies, to be unaffordable, particularly in low- and middle-income nations. Access to these medicines is hampered by high out-of-pocket costs and limited health insurance coverage. Additionally, prompt diagnosis and treatment are hampered by inadequate infrastructure in underserved or rural areas.

Basic allergy drugs are readily accessible, while more sophisticated choices are sometimes limited to urban areas or private healthcare systems. This discrepancy in availability and cost limits market penetration and exacerbates health disparities. To ensure fair growth in the market for allergy treatments, affordability issues and treatment access expansion are still crucial.
Long-Term Treatment Complexity and Patient Adherence:
For many allergy treatments, especially immunotherapies, to be successful, long-term dedication and rigorous adherence to dosage schedules are necessary. individuals may find this difficult, particularly young individuals and those with complicated treatment regimens. Frequent physician visits, side effects, and delayed symptom relief can all lead to poor compliance or treatment cessation.

Additionally, it could be challenging to continuously adhere to lifestyle changes and allergen avoidance techniques. Over time, poor adherence raises healthcare expenses and decreases the effectiveness of treatment. Overcoming this obstacle and guaranteeing effective allergy management results requires strengthening patient education, creating user-friendly delivery systems, and enhancing follow-up care.

Recent Developments in Allergy Treatment Industry

  • Ayvakit and early-stage immunology assets were added when Sanofi paid USD 9.1 billion to purchase Blueprint Medicines in June 2025.
  • April 2025: In line with the 2025-2026 season, ALK-Abbello received European approval for the pediatric use of the Itulazax tree-pollen SLIT tablet.

Key Attributes:

Report Attribute Details
No. of Pages 200
Forecast Period 2024 - 2033
Estimated Market Value (USD) in 2024 $21.08 Billion
Forecasted Market Value (USD) by 2033 $41.93 Billion
Compound Annual Growth Rate 7.9%
Regions Covered Global


Company Analysis: Overview, Key Person, Recent Developments, SWOT Analysis, Revenue Analysis

  • AbbVie Inc.
  • ALK-Abello A/S
  • ALLERGOPHARMA GmbH & Co. KG
  • Almirall, S.A
  • DBV Technologies
  • GSK plc.
  • HAL Allergy B.V.
  • Novartis Pharmaceuticals Corporation
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.

Market Segmentations

Type

  • Eye Allergy
  • Skin Allergy
  • Food Allergy
  • Asthma
  • Rhinitis
  • Others

Treatment

  • Anti-Allergy Drugs
  • Immunotherapy

Dosage Form

  • Oral
  • Inhalers
  • Intranasal
  • Others

Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Retailers
  • Others

Regional Outlook

North America

  • United States
  • Canada

Europe

  • France
  • Germany
  • Italy
  • Spain
  • United Kingdom
  • Belgium
  • Netherlands
  • Turkey

Asia Pacific

  • China
  • Japan
  • India
  • South Korea
  • Thailand
  • Malaysia
  • Indonesia
  • Australia
  • New Zealand

Latin America

  • Brazil
  • Mexico
  • Argentina

Middle East & Africa

  • Saudi Arabia
  • United Arab Emirates
  • South Africa

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

  • Allergy Treatment Global Market
CONTACT: CONTACT: Laura Wood,Senior Press Manager ... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN29092025004107003653ID1110124748

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Search